Updated December 6 at 2:06pm
Biotechnology
71 results total, viewing 61 - 70
Flaws with a heart device that Medtronic PLC bought last month as part of a $1 billion deal have been deemed potentially life-threatening by U.S. regulators. more
After sitting out for most of the biotech acquisition frenzy of 2015, Amgen Inc. is ready to do a deal. more
Southcoast Health recently announced that partial knee replacement surgeries are now being offered with the Navio Surgical System. more
Biotechnology drugmaker AbbVie Inc. filed a lawsuit seeking to block Amgen Inc. from selling a copy of the arthritis medicine Humira, its top seller. more
For all the fuss over tax inversions and the Obama administration’s efforts to prevent them, shares of companies that were able to plow their inversion deals through to the finish line and lock in all those (some would call them nefarious) benefits have to be soaring, right? Not so for Medtronic. more
A key piece of Gov. Gina M. Raimondo's strategy to help create more high-paying jobs is to develop a more robust medical technology and life sciences sector. Four years ago, a group of businesses in the med-tech sector formed an industry … more
At South County Hospital, Rhode Island’s only independent hospital, Dr. Bob Marchand performs full knee replacement surgeries using a high-tech tool that will not be commercially marketed and released until March 2017, he told Providence Business News. more
A top pharmaceutical lobbying group is launching an ad campaign to defend drugmakers that have been under fire for their pricing practices. more
Alexion Pharmaceuticals Inc. this morning hosted a groundbreaking ceremony for an expansion that is expected to double the size of its plant over the next five years. more
Undergraduate students of Rhode Island’s colleges and universities will present their summer research at the ninth annual Rhode Island Summer Undergraduate Research Fellows conference on July 29. more
« Prev | 1 2 | 3 | 4 | 5 | 6 | 7 | 8 Next »